Linda Furlini takes aim at a credulous CBS report on a new Alzheimer’s disease test. In a guest post on Gary Schwitzer's HealthNewsReview.org site, Furlini accuses CBS of overselling the test, thereby abetting the drug industry: "Alzheimer’s disease is complex, but it is in the pharmaceutical industry’s interest to oversimplify it. Clearly, the test reported on by CBS demonstrates medical progress. But, it should have seriously questioned the value of the test."
